Drug Type Small molecule drug |
Synonyms DC-291407, DC-407, DC407 |
Target |
Action inhibitors |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
RegulationSpecial Review Project (China) |
Molecular FormulaC21H21N5O3S |
InChIKeyXKMHHZMODVVEIO-OAHLLOKOSA-N |
CAS Registry1442081-72-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 2 | China | 25 Jul 2022 | |
| Diabetes Mellitus, Type 2 | Phase 2 | China | 25 Jul 2022 | |
| Fatty Liver | Phase 2 | China | 25 Jul 2022 | |
| Fatty Liver | Phase 2 | China | 25 Jul 2022 |





